Plasma Chromogranin a in Prostatic Carcinoma and Neuroendocrine Tumors
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 157 (2) , 565-568
- https://doi.org/10.1016/s0022-5347(01)65203-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Plasma Chromogranin A in Pheochromocytoma, Primary Hyperparathyroidism and Pituitary Adenoma in Comparison with Catecholamine, Parathyroid Hormone and Pituitary Hormones.Endocrine Journal, 1997
- Expression of prohormone convertase, PC2, in adrenocorticotropin- producing thymic carcinoid with elevated plasma corticotropin-releasing hormoneJournal of Clinical Endocrinology & Metabolism, 1996
- Immunoassays for measurement of chromogranin a and pancreastatin-like immunoreactivity in humans: Correspondence in patients with neuroendocrine neoplasiaNeuropeptides, 1994
- Chromogranin a and Pancreastatin-Like Immunoreactivity in Serum of Gastrinoma PatientsActa Oncologica, 1993
- Investigation on serum neurone‐specific enolase in prostate cancer diagnosis and monitoring: Comparative study of a multiple tumor marker assayThe Prostate, 1991
- Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.Journal of Clinical Investigation, 1990
- Hormone-Negative, Chromogranin a-Positive Endocrine TumorsNew England Journal of Medicine, 1989
- How Sensitive and Specific Is Measurement of Plasma Chromogranin A for the Diagnosis of Neuroendocrine Neoplasia?Annals of the New York Academy of Sciences, 1987
- Secretion of Chromogranin A by Peptide-Producing Endocrine NeoplasmsNew England Journal of Medicine, 1986
- Secretion of a Chromaffin Granule Protein, Chromogranin, from the Adrenal Gland after Splanchnic StimulationNature, 1967